Mass tort settlement news from the week of June 1, 2026 brings major developments across pharmaceutical, environmental, and consumer product litigation. Social media companies agreed to pay $27 million to settle a bellwether school district lawsuit. The Roundup opt-out deadline arrived on June 4. Ozempic vision loss cases held a key Science Day hearing. Meanwhile, opioid settlement funds continued flowing to communities nationwide. These stories and more shape a busy week for anyone tracking active MDL cases across the country.
Pharmaceutical Mass Tort Settlement News This Week
The biggest pharmaceutical mass tort settlement news this week centers on GLP-1 drugs. Parker Waichman LLP filed a new Ozempic lawsuit on behalf of a Pennsylvania resident. The plaintiff alleges developing NAION, an irreversible eye condition, after taking Wegovy. MDL No. 3163 now consolidates 73 federal cases. A Science Day hearing on June 2 allowed both sides to present scientific evidence to the presiding judge. A 2026 study found Wegovy users face five times the NAION risk compared to Ozempic users. These proceedings will shape the litigation going forward.
In addition, opioid mass tort settlement news continued to develop. Suffolk County opened its portal for a third round of opioid settlement funds. Maryland launched a new dashboard tracking how communities spend settlement dollars. However, CVS, Walgreens, and Walmart defeated an opioid lawsuit brought by Florida hospitals. For people affected by the opioid crisis, understanding how mass tort settlements work remains essential. Meanwhile, the DOJ filed a statement of interest in a separate opioid case on May 25.
Depo-Provera litigation reached a critical stage. More than 3,769 cases have been filed as of May 2026. Daubert hearings on general causation are scheduled for June 24 through 26. These hearings will determine whether plaintiffs’ expert testimony on meningioma risk is admissible. As a result, the outcome could make or break thousands of claims. Drugwatch also published updated risk information and FDA warnings for Depo-Provera this week. Separately, Takeda faces an $885 million verdict in a landmark pay-for-delay case involving its constipation drug Amitiza.
Medical Device Lawsuit Developments
Medical device mass tort settlement news this week focuses on hernia mesh and port catheter litigation. The hernia mesh MDLs now include over 26,263 combined lawsuits. The Covidien bellwether trial is scheduled for July 13, 2026. Bard’s settlement framework continues processing approximately 38,000 claims. Quick Pay options start at $25,000 for straightforward cases. However, thousands of cases remain parked on the docket while claim review grinds forward.
Meanwhile, a new lawsuit alleges that AngioDynamics port catheter problems led to septic shock. Port catheter litigation continues to grow as more patients report complications. For anyone dealing with a defective medical device, consulting a licensed attorney is an important first step. The eligibility quiz on MassTortInfo.com can help determine whether you may qualify for potential recovery. Paragard IUD cases also remain active, with settlement discussions ongoing in that MDL.
Environmental Contamination Case Updates
Environmental mass tort settlement news this week includes significant PFAS and pesticide developments. Australia filed suit against 3M over firefighting foam PFAS contamination. This international action adds pressure to the ongoing AFFF litigation in the United States. MDL 2873 continues in the District of South Carolina. The PFAS settlement framework ranges from $10.5 to $12.5 billion. Public water suppliers have until 2026 to apply for compensation. Connecticut received another $9.5 million to remove PFAS from drinking water systems.
In addition, Vermont finalized a landmark ban on paraquat this week. The herbicide has been linked to Parkinson’s disease in numerous studies. Syngenta and Chevron quietly settled the first paraquat trial case in Philadelphia. Nearly 6,000 paraquat lawsuits are pending in the MDL. A Master Settlement Agreement has reportedly been signed.
For example, the Roundup litigation offers a parallel. Bayer’s $7.25 billion proposed settlement had its opt-out deadline on June 4. As a result, the tort reform landscape around pesticide liability continues to shift. Anyone exposed to these chemicals should consult a licensed attorney about potential recovery options.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Consumer Product Litigation News
Consumer product mass tort settlement news made headlines this week. Meta, Snap, TikTok, and YouTube agreed to pay $27 million to settle a bellwether school lawsuit. The Breathitt County School District in Kentucky had been selected as a test case. Meta paid $9 million. Snap and ByteDance each paid $8 million. Google contributed $2 million plus training and software. More than 1,300 other school districts have filed similar lawsuits. Bloomberg Intelligence estimates total liability could reach $400 billion.
Meanwhile, a new lawsuit alleges Roblox safety promises are misleading parents. Talcum powder litigation also remains active. The J&J talc MDL grew to 67,623 pending cases. Judge Lopez rejected the proposed $8 billion bankruptcy settlement. A mediator convened a settlement session in April under Judge Shipp’s order. The first federal bellwether trial remains on track for later in 2026.
In the hair relaxer litigation, cases continue to build. For a deeper understanding of these cases, visit our guide on what is a mass tort. The Similac NEC lawsuit also saw a $17 million punitive damages increase in April.
Key Deadlines and What to Watch
Several critical dates loom in mass tort settlement news for June 2026. The Depo-Provera Daubert hearings on June 24 through 26 could determine the future of nearly 4,000 claims. The Covidien hernia mesh bellwether trial is set for July 13. The Roundup opt-out deadline passed on June 4. Meanwhile, the Tepezza hearing loss trial date has been pushed to August 2026.
Looking ahead, the social media school district litigation moves to its next trial in February 2027. The J&J talc federal bellwether is expected later this year. PFAS water supplier claims must be filed before the 2026 deadline closes. For the latest updates on all mass tort settlement news, bookmark MassTortInfo.com and check back weekly. If you believe you were harmed by any product or substance discussed above, speak with a licensed attorney to explore your options for potential recovery.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed June 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- New Jersey Tort Reform Guide
- Pennsylvania Tort Reform Guide
- Georgia Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.